About UCSF Search UCSF UCSF Medical Center

News

Killing Cancer Through the Immune System (Part II)

Killing Cancer Through the Immune System (Part II)

February 4, 2014

"For the longest time, people did not believe this was possible," said Lawrence Fong, MD, associate professor of medicine at UCSF and one of the University’s lead investigators in the expanding use of immunotherapy.

Killing Cancer Through the Immune System

Killing Cancer Through the Immune System

February 4, 2014

One of the confounding characteristics of cancer has long been that the body’s usually active patrol against viruses tends to leave deadly cancer cells alone to fester, mutate and spread.

Scientists Call for Screening Mammography Every Two Years for Most Women

Scientists Call for Screening Mammography Every Two Years for Most Women

February 3, 2014

Adoption of new guidelines recommending screening mammography every two years for women ages 50 to 74 would result in breast cancer screening that is equally effective, while saving the United States $4.3 billion a year in health care costs, according to a study led by UC San Francisco.

ExRNA Research May Refine Prostate Cancer Treatment

ExRNA Research May Refine Prostate Cancer Treatment

February 3, 2014

Urology faculty member Robert Blelloch, MD, PhD, is leading an NIH-funded project examining the role extracellular RNA (exRNA) might play in prostate and other cancers. 

UCSF Resource Allocation Program (RAP) Seeks Applications for Spring 2014 Cycle

UCSF Resource Allocation Program (RAP) Seeks Applications for Spring 2014 Cycle

January 29, 2014

UCSF's Resource Allocation Program (RAP), which offers a single online application process for a wide variety of intramural grant offerings, is now inviting applications for the Spring 2014 cycle.

Biases in Animal Studies May Differ From Those In Clinical Trials, UCSF Study Finds

Biases in Animal Studies May Differ From Those In Clinical Trials, UCSF Study Finds

January 24, 2014

A new analysis of animal studies on cholesterol-lowering statins by UC San Francisco researchers found that non-industry studies had results that favored the drugs even more than studies funded by industry.